公开(公告)号：US07067314B2

公开(公告)日：2006-06-27

申请号：US10172986

申请日：2002-06-18

申请人： Takaaki Ohara ,  Kenji Yamashita ,  Tetsu Kakutani ,  Seishi Kyoizumi

发明人： Takaaki Ohara ,  Kenji Yamashita ,  Tetsu Kakutani ,  Seishi Kyoizumi

IPC分类号： C12N5/06 ,  G01N33/543 ,  G07K16/00 ,  C12P21/08

CPC分类号： C07K16/28 ,  C07K14/47 ,  G01N33/56966

摘要： It is an object to utilize a novel HSCA-3 antigen occurring in immature hemopoietic stem cells and a monoclonal antibody recognizing said antigen in 1) the immunoassay or flow cytometry involving antibody labeling and 2) the isolation and purification of immature hemopoietic stem cells from human bone marrow cells, umbilical code blood or blood enriched in human hemopoietic stem cells by mobilization with G-CSF.It is directed to a novel HSCA-3 antigen occurring in immature hemopoietic stem cells and to a monoclonal antibody or an immunoreactive fragment thereof which recognizes said antigen.

摘要翻译： 本发明的目的是利用在未成熟造血干细胞中发生的新型HSCA-3抗原和识别所述抗原的单克隆抗体，1）免疫测定或流式细胞术涉及抗体标记和2）从人类分离和纯化未成熟造血干细胞 骨髓细胞，脐带血或富含人造血干细胞的血液用G-CSF动员。 涉及发生在未成熟造血干细胞中的新型HSCA-3抗原以及识别所述抗原的单克隆抗体或其免疫反应性片段。

公开(公告)号：US5556943A

公开(公告)日：1996-09-17

申请号：US328152

申请日：1994-10-24

申请人： Kenji Yamashita ,  Takaaki Ohara ,  Hideo Niwa ,  Fumio Osakada ,  Takeshi Fukuchi ,  Tadahiro Edamura ,  Tetsu Kakutani

发明人： Kenji Yamashita ,  Takaaki Ohara ,  Hideo Niwa ,  Fumio Osakada ,  Takeshi Fukuchi ,  Tadahiro Edamura ,  Tetsu Kakutani

IPC分类号： A61K38/00 ,  C07K14/705 ,  C12N1/21 ,  C12N15/12 ,  C07K14/47

CPC分类号： C07K14/70528 ,  A61K38/00

摘要： A sheep LFA-3 protein and derivertires thereof, and derivertives of a human LFA-3 protein, gene coding for the proteins, and processes for preparing the proteins. Said proteins have high affinity for human T-cells.

摘要翻译： 绵羊LFA-3蛋白质及其衍生物，人LFA-3蛋白质的衍生物，编码蛋白质的基因，以及制备蛋白质的方法。 所述蛋白质对人T细胞具有高亲和力。

公开(公告)号：US4988624A

公开(公告)日：1991-01-29

申请号：US882109

申请日：1986-07-03

申请人： Tetsu Kakutani ,  Kenji Yamashita ,  yasuhiro Ikenaka ,  Hajime Kawaharada ,  Kiyoshi Watanabe

发明人： Tetsu Kakutani ,  Kenji Yamashita ,  yasuhiro Ikenaka ,  Hajime Kawaharada ,  Kiyoshi Watanabe

IPC分类号： C07K14/525 ,  C12N15/19 ,  C12N15/85

CPC分类号： C07K14/525 ,  C12N15/85

摘要： A chromosomal DNA sequence which codes for human lymphotoxin, a lymphotoxin expression vector which contains a DNA sequence wherein a chromosomal DNA sequence coding for human lymphotoxin and promoter region which functions in animal cell are linked together, lymphotoxin resistant cell line, transformed animal cell culture which is formed by transforming cultured animal cell with a lymphotoxin expression vector which contains a chromosomal DNA sequence coding for human lymphotoxin and, a process for preparing human lymphotoxin, which comprises transforming cultured animal cell with a lymphotoxin expression vector which contains a chromosomal DNA sequence coding for human lymphotoxin, culturing the transformed cell culture to produce human lymphotoxin, and collecting the human lymphotoxin.According to the present invention, LT which is expected for application as the antitumor agent can be produced effectively in a large amount.

摘要翻译： 编码人淋巴毒素的染色体DNA序列，含有DNA序列的淋巴毒素表达载体，其中编码人类淋巴毒素的染色体DNA序列和在动物细胞中起作用的启动子区连接在一起，淋巴毒素抗性细胞系，转化的动物细胞培养物 是通过用含有编码人淋巴毒素的染色体DNA序列的淋巴毒素表达载体转化培养的动物细胞，以及制备人淋巴毒素的方法形成的，其包括用含有染色体DNA序列编码的淋巴毒素表达载体转化培养的动物细胞， 人淋巴毒素，培养转化的细胞培养物以产生人淋巴毒素，并收集人淋巴毒素。 根据本发明，可以有效地大量生产预期用作抗肿瘤剂的LT。

公开(公告)号：US5407819A

公开(公告)日：1995-04-18

申请号：US869380

申请日：1992-04-16

申请人： Hitoshi Yahara ,  Tetsuya Nagaoka ,  Kazuyoshi Yajima ,  Yasuhiro Inenaka ,  Keiji Matsumoto ,  Tetsu Kakutani

发明人： Hitoshi Yahara ,  Tetsuya Nagaoka ,  Kazuyoshi Yajima ,  Yasuhiro Inenaka ,  Keiji Matsumoto ,  Tetsu Kakutani

IPC分类号： C12N9/72 ,  C12N15/58 ,  C12N5/00 ,  C12N15/00 ,  A61K37/547

CPC分类号： C12N9/6459 ,  C12Y304/21069

摘要： A TPA variant with replacement of amino acids is provided. In a typical embodiment, the variant has an amino acid sequence with replacement of the amino acid group consisting of asparagine at the 37th position, serine at the 38th position, glycine at the 39th position, arginine at the 40th position, alanine at the 41st position, and glutamine at the 42nd position from the N-terminus of the amino acid sequence of mature human tissue plasminogen activator.

摘要翻译： 提供了具有替换氨基酸的TPA变体。 在典型的实施方案中，变体具有氨基酸序列，其替换由第37位天冬酰胺，第38位丝氨酸，第39位甘氨酸，第40位精氨酸，第41位丙氨酸组成的氨基酸组 ，和谷氨酰胺在成熟的人组织纤溶酶原激活物的氨基酸序列的N末端的第42位。

公开(公告)号：US4970161A

公开(公告)日：1990-11-13

申请号：US144988

申请日：1988-01-19

申请人： Tetsu Kakutani ,  Keiji Matsumoto ,  Hiroyuki Maruyama ,  Kaku Nakagawa ,  Shinichi Yokota ,  Hideo Niwa ,  Katsuhiro Shinjo ,  Hajime Kawaharada ,  Kiyoshi Watanabe

发明人： Tetsu Kakutani ,  Keiji Matsumoto ,  Hiroyuki Maruyama ,  Kaku Nakagawa ,  Shinichi Yokota ,  Hideo Niwa ,  Katsuhiro Shinjo ,  Hajime Kawaharada ,  Kiyoshi Watanabe

IPC分类号： C07K14/57 ,  C12N15/23

CPC分类号： C07K14/57

摘要： A DNA sequence on which a chromosomal DNA sequence coding for human interferon-.gamma. (HuIFN-.gamma.) and having a TATA box is ligated to a sequence of a promoter. Cell cultures transformed with said DNA revealed a higher expression of HuIFN- than cell cultures transformed with a DNA which does not have such TATA box. When transformed with said DNA, cell cultures produced HuIFN-.gamma. in a serum free medium. Transformed cell cultures derived from blood cells of HuIFN-.gamma. resistant human cell-line also could produce HuIFN-.gamma..

摘要翻译： 将编码人干扰素-γ（HuIFN-γ）并具有TATA盒的染色体DNA序列连接到启动子序列的DNA序列。 用所述DNA转化的细胞培养物显示出用不具有这种TATA盒的DNA转化的细胞培养物更高的HuIFN表达。 当用所述DNA转化时，细胞培养物在无血清培养基中产生HuIFN-γ。 来自HuIFN-γ抗性人细胞系血细胞的转化细胞培养物也可产生HuIFN-γ。